Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesPrimary and Secondary Prevention of Cardiovascular Diseases: A Practical Evidence-Based Approach
Mayo Clinic Proceedings, 08/05/09
O'Keefe JH et al. – Therapeutic lifestyle changes in conjunction with an aggressive multidrug regimen targeted toward the normalization of the major CV risk factors will neutralize the atherogenic milieu, reduce vascular inflammation, and markedly decrease the risk of adverse CV events and need for revascularization procedures. Specific CV risk factors and optimal therapies for primary and secondary prevention are discussed.
Related Articles
Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: A matched-pair cohort study
Arthritis & Rheumatism, 11/05/09
Relevance Score: 71%
Chronic renal insufficiency, cardiovascular disease and mortality in women: a causal relationship or coincidence?
Women's Health, 11/02/09
Relevance Score: 70%
Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmö, Sweden
Rheumatology, 10/30/09
Relevance Score: 70%
Frequency of migraine and the risk of cardiovascular disease for women: limited evidence of an association
Women's Health, 10/30/09
Relevance Score: 69%
Systemic lupus erythematosus and the risk of cardiovascular disease: Results from the Nurses Health Study
Arthritis Care and Research, 10/01/09
Relevance Score: 69%
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/08/09
Review: aspirin reduces vascular events but increases bleeding in primary and secondary prevention
Evidence-Based Medicine, 12/08/09
Review: aspirin does not reduce CV events but may reduce non-fatal stroke in peripheral artery disease
Evidence-Based Medicine, 12/08/09
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
The formation of monocyte–platelet aggregates is independent of on-treatment residual agonists’-inducible platelet reactivity
Atherosclerosis, 12/08/09
Review: aspirin reduces vascular events but increases bleeding in primary and secondary prevention
Evidence-Based Medicine, 12/08/09
Review: aspirin does not reduce CV events but may reduce non-fatal stroke in peripheral artery disease
Evidence-Based Medicine, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor